The emotional impact of surveillance programs for pancreatic cancer on high-risk individuals: A prospective analysis.
Adaptation, Psychological
Adult
Anxiety
/ psychology
Attitude to Health
Early Detection of Cancer
/ psychology
Female
Humans
Male
Middle Aged
Pancreatic Neoplasms
/ diagnosis
Prospective Studies
Social Support
Stress, Psychological
/ psychology
Surveys and Questionnaires
Young Adult
Pancreatic Neoplasms
cancer
cancer worries
coping strategies
emotional impact
high-risk individuals
oncology
pancreatic cancer
psychological burden
surveillance
Journal
Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
22
10
2019
revised:
21
02
2020
accepted:
23
02
2020
pubmed:
29
2
2020
medline:
17
12
2020
entrez:
29
2
2020
Statut:
ppublish
Résumé
Literature shows that emotional status can influence participation in screening/surveillance programs, and that screening/surveillance programs may alter the psychological well-being of subjects examined. This study aims to assess if participating in a surveillance program for pancreatic cancer early detection is associated with abnormal levels of psychological distress in high-risk individuals (HRIs), compared to the general population. Fifty-four HRIs participating in a magnetic resonance cholangiopancreatography (MRCP)-based surveillance program completed several psychological assessment questionnaires, investigating global functioning, self-efficacy, perceived stress, coping abilities, and social support. The questionnaires were administered by a clinical psychologist after the MRCP but before the subjects were informed about the results of the scans. The HRIs were subjects with strong familiarity of pancreatic cancer and/or carriers of known genetic mutations related to cancer susceptibility. The psychological assessment was made at the time of the first examination. The population was characterized by an overall good psychological status. Scoring of our sample was comparable to the general population norms. The HRIs showed decent global functioning, high self-efficacy levels, low perceived stress in the last month prior to examination, efficient emotion-focused coping strategies, and an adequate social support system. The younger subjects' subpopulation only revealed higher levels of stress. From a psychological point of view, an MRCP-based pancreatic cancer annual surveillance seemed not to influence the HRIs' psychological well-being, unless in young people. Further studies are needed to better establish if there are any changes in distress levels over time and how emotional status influences participation in surveillance programs.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1004-1011Informations de copyright
© 2020 John Wiley & Sons, Ltd.
Références
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7-30.
Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271-289.
Canto MI, Harinck F, Hruban RH, et al. International Cancer Of The Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut. 2013;62(3):339-347.
Paiella S, Salvia R, De Pastena M, et al. Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: a systematic review and proportion meta-analysis of screening results. Pancreatology. 2018;18(4):420-428.
Signoretti M, Bruno MJ, Zerboni G, Poley JW, Delle Fave G, Capurso G. Results of surveillance in individuals at high-risk of pancreatic cancer: a systematic review and meta-analysis. United European Gastroenterol J. 2018;6(4):489-499.
Absetz P, Aro AR, Sutton SR. Experience with breast cancer, pre-screening perceived susceptibility and the psychological impact of screening. Psychooncology. 2003;12(4):305-318.
Andersen MR, Drescher CW, Zheng Y, et al. Changes in cancer worry associated with participation in ovarian cancer screening. Psychooncology. 2007;16(9):814-820.
Maheu C, Vodermaier A, Rothenmund H, et al. Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning. Fam Cancer. 2010;9(4):617-624.
Konings IC, Harinck F, Kuenen MA, et al. Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance. Fam Cancer. 2017;16(1):143-151.
Harinck F, Nagtegaal T, Kluijt I, et al. Feasibility of a pancreatic cancer surveillance program from a psychological point of view. Genet Med. 2011;13(12):1015-1024.
Konings IC, Sidharta GN, Harinck F, et al. Repeated participation in pancreatic cancer surveillance by high-risk individuals imposes low psychological burden. Psychooncology. 2016;25(8):971-978.
O'Neill RS, Meiser B, Emmanuel S, Williams DB, Stoita A. Long-term positive psychological outcomes in an Australian pancreatic cancer screening program. Fam Cancer. 2020;19(1):23-35. https://doi.org/10.1007/s10689-019-00147-3
Cazacu IM, Luzuriaga Chavez AA, Saftoiu A, Bhutani MS. Psychological impact of pancreatic cancer screening by EUS or magnetic resonance imaging in high-risk individuals: a systematic review. Endosc Ultrasound. 2019;8(1):17-24.
Paiella S, Capurso G, Cavestro GM, et al. Results of first-round of surveillance in individuals at high-risk of pancreatic cancer from the AISP (Italian Association for the Study of the pancreas) registry. Am J Gastroenterol. 2019;114(4):665-670.
Barratt W. Barratt simplified measure of social status (BSMSS) measuring SES; 2006. http://wbarratt.indstate.edu/socialclass/Barratt_Simplifed_Measure_of_Social_Status.pdf. Accessed July 20, 2019.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed.Text Revision (DSM-IV-TR) Washington, DC: American Psychiatric Association; 2000.
Schwarzer R, Jerusalem M. Generalized self-efficacy scale. In: Weinman J, Wright S, Johnston M, eds. Measures in Health Psychology: A user's Portfolio Causal and Control Beliefs. Windsor, UK: NFER-NELSON; 1995:35-37.
Sibilia L, Schwarzer R, Jerusalem M. Italian adaptation of the general self-efficacy scale; 1995. http://userpage.fu-berlin.de/health/italian.htm. Accessed December 07, 2019.
Taylor JM. Psychometric Analysis Of The Ten-Item Perceived Stress Scale. Psychol Assess. 2015;27(1):90-101.
Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med. 1997;4(1):92-100.
Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol. 1989;56(2):267-283.
Cooper C, Katona C, Orrell M, Livingston G. Coping strategies and anxiety in caregivers of people with Alzheimer's disease: the LASER-AD study. J Affect Disord. 2006;90(1):15-20.
Zimet GD, Dahlem NW, Zimet SG, Farley GK. The multidimensional scale of perceived social support. J Pers Assess. 1988;52(1):30-41.
Prezza M, Principato MC. La rete e il sostegno sociale. In: Prezza M, Santinello M, eds. Conoscere la comunitàConoscere la comunità Bologna. Il Mulino; 2002:193-233.
Sach TH, Whynes DK. Men and women: beliefs about cancer and about screening. BMC Public Health. 2009;9:431.
Hart SL, Torbit LA, Crangle CJ, et al. Moderators of cancer-related distress and worry after a pancreatic cancer genetic counseling and screening intervention. Psychooncology. 2012;21(12):1324-1330.
Underhill M, Hong F, Lawrence J, Blonquist T, Syngal S. Relationship between individual and family characteristics and psychosocial factors in persons with familial pancreatic cancer. Psychooncology. 2018;27(7):1711-1718.
Heinze G, Wallisch C, Dunkler D. Variable selection-a review and recommendations for the practicing statistician. Biom J. 2018;60(3):431-449.
Cohen S, Williamson G. Perceived stress in a probability sample of the United States. In: SOE SS, ed. The Social Psychology of Health: Claremont Symposium on Applied Social Psychology. Newbury Park, CA: Sage; 1988:31-67.
Hay JL, Buckley TR, Ostroff JS. The role of cancer worry in cancer screening: a theoretical and empirical review of the literature. Psychooncology. 2005;14(7):517-534.
Marinelli V, Secchettin E, Andrianello S, et al. Psychological distress in patients under surveillance for intraductal papillary mucinous neoplasms of the pancreas: the "Sword of Damocles" effect calls for an integrated medical and psychological approach a prospective analysis. Pancreatology. 2020.
Lindfors KK, O'Connor J, Parker RA. False-positive screening mammograms: effect of immediate versus later work-up on patient stress. Radiology. 2001;218(1):247-253.
Sherwood P, Given BA, Given CW, et al. A cognitive behavioral intervention for symptom management in patients with advanced cancer. Oncol Nurs Forum. 2005;32(6):1190-1198.
Wilson JMG, Jungner G. Principles and Practices of Screening for Disease. Geneva, Switzerland: World Health Organization. Report No.: Public Health Papers No. 34. Available from: http://whqlibdoc.who.int/php/WHO_PHP_34.pdf; 1968.
Gordon LU. Validities of the forced-choice and questionnaire methods of personality measurement. J Appl Psychol. 1951;35(6):407-412.
Persoskie A, Leyva B, Ferrer RA. Mode effects in assessing cancer worry and risk perceptions: is social desirability bias at play? Med Decis Making. 2014;34(5):583-589.
Franke FS, Matthai E, Slater EP, Schicker C, Kruse J, Bartsch DK. German National Case Collection for familial pancreatic Cancer (FaPaCa)-acceptance and psychological aspects of a pancreatic cancer screening program. Hered Cancer Clin Pract. 2018;16:17.
Underhill-Blazey M, Blonquist T, Lawrence J, Hong F, Yurgelun MB, Syngal S. Health behaviours and beliefs in individuals with familial pancreatic cancer. Fam Cancer. 2019;18(4):457-464.
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.